Kazakh AI Startup 'Defect AI' Joins Stanford University's Elite StartX Accelerator to Target U.S. Healthcare Market

Astana Hub's Defect AI (Rette) accepted into Stanford's 2026 StartX cohort. Learn how this Kazakh AI startup is automating U.S. medical documentation.

By: AXL Media

Published: Mar 4, 2026, 8:06 AM EST

Source: The information in this article was sourced from The Times of Central Asia

Breaking into Silicon Valley

In a significant milestone for Central Asia’s tech ecosystem, the Kazakhstan-based startup Defect AI has secured a spot in the Spring 2026 cohort of the StartX accelerator at Stanford University. Known as one of the most exclusive and competitive programs in Silicon Valley, StartX provides a launchpad for high-potential technology projects. The acceptance comes after a persistent effort by the founding team, led by co-founder Sanzhar Myrzagalym, who revealed that the startup had applied four times before finally gaining admission.

AI-Driven Efficiency in Healthcare

The core product developed by Defect AI (operating globally under the brand Rette) is an artificial intelligence platform designed to revolutionize medical administration. The algorithm analyzes medical documentation to ensure compliance with regulatory standards, effectively serving as an AI assistant for healthcare organizations. According to the developers, the technology can:

Reduce manual document verification time by up to 95%.

Structure complex medical data without requiring additional administrative staff.